Literature DB >> 30391763

Management of Residual and Recurrent Aneurysms After Clipping or Coiling: Clinical Characteristics, Treatments, and Follow-Up Outcomes.

Le-Bao Yu1, Zhi-Jun Fang2, Xin-Jian Yang3, Dong Zhang4.   

Abstract

BACKGROUND: Recurrent intracranial aneurysms (RAs) remain a daunting challenge for neurosurgeons. This study aimed to explore a potential optimal management strategy of RAs by reviewing the characteristics and management outcomes of 117 RAs.
METHODS: A total of 117 patients with RAs were treated in a single neurosurgical center from January 2011 to January 2017. The demographic and angiographic characteristics of the patients, treatment approaches, and follow-up outcomes were evaluated.
RESULTS: Of the 117 patients with RAs, 16 (13.7%) and 101 (86.3%) initially underwent microsurgical clipping and endovascular coiling, respectively. Coil embolization was used in 75 cases, microsurgical clipping was used in 32 cases, and conservative treatment occurred in 10 cases. Complete clipping was achieved in all 32 aneurysms by microsurgery, and remnants were observed in 25 aneurysms after coiling (33.3%, P < 0.001). Operation-related cerebral infarction occurred in 4 cases (12.5%) with complex and large RA in the clipping group and in 1.3% (1/75) of patients treated with coiling (P = 0.027). Follow-up found similar favorable outcomes in patients after coiling, clipping, and conservative treatment (90.3% vs. 86.7% vs. 80%, respectively; P = 0.711). Follow-up rates of recurrence were significantly higher in the coiling group than the clipping group (26% vs. 0%, respectively; P = 0.003).
CONCLUSIONS: The follow-up outcomes appeared to be acceptable and comparable between the 2 groups. However, in large or giant recurrent aneurysms, sound judgment and the careful selection of treatment are strongly suggested because direct microsurgery has a higher morbidity, even in experienced hands, whereas endovascular coiling is complicated with a higher incomplete occlusion rate.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Endovascular coiling; Microsurgical clipping; Recurrent aneurysm

Mesh:

Year:  2018        PMID: 30391763     DOI: 10.1016/j.wneu.2018.10.160

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  5 in total

1.  Incidence rate and predictors of recurrent aneurysms after clipping: long-term follow-up study of survivors of subarachnoid hemorrhage.

Authors:  Hyun Jin Han; Woosung Lee; Junhyung Kim; Keun Young Park; Sang Kyu Park; Joonho Chung; Yong Bae Kim
Journal:  Neurosurg Rev       Date:  2022-06-23       Impact factor: 2.800

Review 2.  MICROSURGICAL MANAGEMENT OF RECURRENT INTRACRANIAL ANEURYSMS FOLLOWING ENDOVASCULAR TREATMENT: A SINGLE INSTITUTION ILLUSTRATIVE CASE SERIES AND LITERATURE REVIEW.

Authors:  Krešimir Rotim; Vladimir Kalousek; Filip Vrban; Bruno Splavski
Journal:  Acta Clin Croat       Date:  2021-12       Impact factor: 0.932

3.  Microsurgery of residual or recurrent complex intracranial aneurysms after coil embolization - a quest for the ultimate therapy.

Authors:  Ariyan Pirayesh; Nakao Ota; Kosumo Noda; Ioannis Petrakakis; Hiroyasu Kamiyama; Sadahisa Tokuda; Rokuya Tanikawa
Journal:  Neurosurg Rev       Date:  2020-03-24       Impact factor: 3.042

4.  Management of Recurrent Aneurysms after Endovascular Coiling: A Fujita Experience.

Authors:  Raja K Kutty; Ambuj Kumar; Yasuhiro Yamada; Riki Tanaka; Satish Kannan; Vigneshwar Ravisankar; Aaron Musara; Kyosuke Miyatani; Saeko Higashiguchi; Katsumi Takizawa; Tsukasa Kawase; Yoko Kato
Journal:  Asian J Neurosurg       Date:  2019-11-25

5.  Residual lesions in patients undergoing microsurgical clipping of cerebral aneurysms in a reference university hospital.

Authors:  Guilherme Brasileiro de Aguiar; Matheus Kohama Kormanski; Carolina Junqueira Tavares Corrêa; Andrew Vinícius de Souza Batista; Mario Luiz Marques Conti; José Carlos Esteves Veiga
Journal:  Clinics (Sao Paulo)       Date:  2020-10-26       Impact factor: 2.365

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.